155 related articles for article (PubMed ID: 21193920)
1. The follow-up of patients with head and neck cancer: an analysis of 1,039 patients.
Kothari P; Trinidade A; Hewitt RJD; Singh A; O'Flynn P
Eur Arch Otorhinolaryngol; 2011 Aug; 268(8):1191-1200. PubMed ID: 21193920
[TBL] [Abstract][Full Text] [Related]
2. Post-Treatment Head and Neck Cancer Care: National Audit and Analysis of Current Practice in the United Kingdom.
INTEGRATE (The UK ENT Trainee Research Network)
Clin Otolaryngol; 2021 Jan; 46(1):284-294. PubMed ID: 32734679
[TBL] [Abstract][Full Text] [Related]
3. The value of routine follow-up after treatment for head and neck cancer. A national survey from DAHANCA.
Pagh A; Vedtofte T; Lynggaard CD; Rubek N; Lonka M; Johansen J; Andersen E; Kristensen CA; von Buchwald C; Andersen M; Godballe C; Overgaard J; Grau C
Acta Oncol; 2013 Feb; 52(2):277-84. PubMed ID: 23320772
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy.
Ng SP; Pollard C; Berends J; Ayoub Z; Kamal M; Garden AS; Bahig H; Cantor SB; Schaefer AJ; Ajayi T; Gunn GB; Frank SJ; Skinner H; Phan J; Morrison WH; Ferrarotto R; Johnson JM; Mohamed ASR; Lai SY; Hessel AC; Sturgis EM; Weber RS; Fuller CD; Rosenthal DI
Cancer; 2019 Jun; 125(11):1823-1829. PubMed ID: 30748005
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound in patients with treated head and neck carcinomas: A retrospective analysis for effectiveness of follow-up care.
Jiang H; Tan Q; He F; Yang W; Liu J; Zhou F; Zhang M
Medicine (Baltimore); 2021 Apr; 100(16):e25496. PubMed ID: 33879682
[TBL] [Abstract][Full Text] [Related]
6. [Routine follow-up in patients treated of head and neck cancer].
Wierzbicka M; Waśniewska E; Jackowska J; Leszczyńska M; Szyfter W
Otolaryngol Pol; 2012; 66(2):138-47. PubMed ID: 22500505
[TBL] [Abstract][Full Text] [Related]
7. Symptom-based remote assessment in post-treatment head and neck cancer surveillance: A prospective national study.
Zhang H; Hardman JC; Tikka T; Nankivell P; Mehanna H; Paleri V;
Clin Otolaryngol; 2022 Sep; 47(5):561-567. PubMed ID: 35634790
[TBL] [Abstract][Full Text] [Related]
8. A longitudinal study of follow-up activities after curative treatment for head and neck cancer.
Pagh A; Grau C; Overgaard J
Acta Oncol; 2015 May; 54(5):813-9. PubMed ID: 25907822
[TBL] [Abstract][Full Text] [Related]
9. Surveillance of Patients with Head and Neck Cancer with an Intensive Clinical and Radiologic Follow-up.
Imbimbo M; Alfieri S; Botta L; Bergamini C; Gloghini A; Calareso G; Orlandi E; Iacovelli NA; Guzzo M; Granata R; Resteghini C; Locati L; Volpi CC; Licitra L; Bossi P
Otolaryngol Head Neck Surg; 2019 Oct; 161(4):635-642. PubMed ID: 31286827
[TBL] [Abstract][Full Text] [Related]
10. PET-CT and the detection of the asymptomatic recurrence or second primary lesions in the treated head and neck cancer patient.
Dunsky KA; Wehrmann DJ; Osman MM; Thornberry BM; Varvares MA
Laryngoscope; 2013 Sep; 123(9):2161-4. PubMed ID: 23817791
[TBL] [Abstract][Full Text] [Related]
11. Recurrent head and neck cancer: United Kingdom National Multidisciplinary Guidelines.
Mehanna H; Kong A; Ahmed SK
J Laryngol Otol; 2016 May; 130(S2):S181-S190. PubMed ID: 27841130
[TBL] [Abstract][Full Text] [Related]
12. Role of the physician versus the patient in the detection of recurrent disease following treatment for head and neck cancer.
Agrawal A; deSilva BW; Buckley BM; Schuller DE
Laryngoscope; 2004 Feb; 114(2):232-5. PubMed ID: 14755196
[TBL] [Abstract][Full Text] [Related]
13. 'When will I see you again?' Using local recurrence data to develop a regimen for routine surveillance in post-treatment head and neck cancer patients.
Lester SE; Wight RG
Clin Otolaryngol; 2009 Dec; 34(6):546-51. PubMed ID: 20070764
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of current regular follow-up policy after treatment for head and neck cancer: Need for individualized and obligatory follow-up strategy.
Jung YH; Song CM; Park JH; Kim H; Cha W; Hah JH; Kwon TK; Kim KH; Sung MW
Head Neck; 2014 May; 36(5):715-21. PubMed ID: 23616261
[TBL] [Abstract][Full Text] [Related]
15. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck.
Boysen M; Lövdal O; Tausjö J; Winther F
Eur J Cancer; 1992; 28(2-3):426-30. PubMed ID: 1591057
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient.
Lonneux M; Lawson G; Ide C; Bausart R; Remacle M; Pauwels S
Laryngoscope; 2000 Sep; 110(9):1493-7. PubMed ID: 10983949
[TBL] [Abstract][Full Text] [Related]
17. Remote triage incorporating symptom-based risk stratification for suspected head and neck cancer referrals: A prospective population-based study.
Hardman JC; Tikka T; Paleri V;
Cancer; 2021 Nov; 127(22):4177-4189. PubMed ID: 34411287
[TBL] [Abstract][Full Text] [Related]
18. Post-treatment surveillance of head and neck cancer: pitfalls in the interpretation of FDG PET-CT/MRI.
Meerwein CM; Queiroz M; Kollias S; Hüllner M; Veit-Haibach P; Huber GF
Swiss Med Wkly; 2015; 145():w14116. PubMed ID: 25701645
[TBL] [Abstract][Full Text] [Related]
19. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT.
Kubota K; Yokoyama J; Yamaguchi K; Ono S; Qureshy A; Itoh M; Fukuda H
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):590-5. PubMed ID: 14722678
[TBL] [Abstract][Full Text] [Related]
20. Self-reported Symptoms to Monitor Recurrent Head and Neck Cancer-Analysis of 1,678 Cases.
Boysen ME; Zätterström UK; Evensen JF
Anticancer Res; 2016 Jun; 36(6):2849-54. PubMed ID: 27272796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
